IPHA
Price
$1.98
Change
-$0.03 (-1.49%)
Updated
Apr 25 closing price
Capitalization
167.56M
15 days until earnings call
QSI
Price
$1.23
Change
+$0.01 (+0.82%)
Updated
Apr 25 closing price
Capitalization
225.27M
17 days until earnings call
Ad is loading...

IPHA vs QSI

Header iconIPHA vs QSI Comparison
Open Charts IPHA vs QSIBanner chart's image
Innate Pharma SA
Price$1.98
Change-$0.03 (-1.49%)
Volume$29.17K
Capitalization167.56M
Quantum-Si
Price$1.23
Change+$0.01 (+0.82%)
Volume$3.24M
Capitalization225.27M
IPHA vs QSI Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. QSI commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and QSI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (IPHA: $1.98 vs. QSI: $1.23)
Brand notoriety: IPHA and QSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 59% vs. QSI: 50%
Market capitalization -- IPHA: $167.56M vs. QSI: $225.27M
IPHA [@Biotechnology] is valued at $167.56M. QSI’s [@Biotechnology] market capitalization is $225.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, IPHA is a better buy in the long-term than QSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while QSI’s TA Score has 4 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 5 bearish.
  • QSI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, QSI is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а +0.51% price change this week, while QSI (@Biotechnology) price change was +6.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

IPHA is expected to report earnings on May 13, 2025.

QSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QSI($225M) has a higher market cap than IPHA($168M). IPHA YTD gains are higher at: 7.609 vs. QSI (-54.444).
IPHAQSIIPHA / QSI
Capitalization168M225M75%
EBITDAN/A-103.98M-
Gain YTD7.609-54.444-14%
P/E RatioN/AN/A-
RevenueN/A3.06M-
Total CashN/A210M-
Total DebtN/A12.9M-
TECHNICAL ANALYSIS
Technical Analysis
IPHAQSI
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
72%
MACD
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSTIX12.290.18
+1.49%
Goldman Sachs Strategic Growth Instl
MUIFX29.140.18
+0.62%
Nationwide Institutional Service
IHSAX18.070.05
+0.28%
Hartford Small Company A
CRMEX5.97N/A
N/A
CRM All Cap Value Inv
AEIUX8.34-0.02
-0.24%
American Century Equity Income R5

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-1.49%
MDGL - IPHA
43%
Loosely correlated
+2.14%
SLNO - IPHA
34%
Loosely correlated
-1.31%
VALN - IPHA
30%
Poorly correlated
+0.57%
QSI - IPHA
28%
Poorly correlated
+0.82%
VKTX - IPHA
27%
Poorly correlated
-2.61%
More